Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMMONWEALTH BIOTECHNOLOGIES INC | 125,000 | reported | 22 Dec 2020 | tx 13+14,498,500−10,040,956 |
| ACCENTIA BIOPHARMACEUTICALS INC | 109,654 | reported | 24 Aug 2012 | tx 2+209,654 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Dec 2020 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 125,000 | 0.00 USD | deriv |
| 17 Sept 2020 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 100,000 | 0.00 USD | deriv |
| 02 Dec 2019 | PURCHASE | COMMONWEALTH BIOTECHNOLOGIES INC | 13,500 | 0.07 USD | |
| 30 Aug 2018 | SALE | COMMONWEALTH BIOTECHNOLOGIES INC | 100,000 | 0.27 USD | |
| 13 Mar 2018 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 260,000 | 0.00 USD | deriv |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | — | |
| 08 Mar 2017 | TAX_WITHHOLDING | COMMONWEALTH BIOTECHNOLOGIES INC | 1,470,478 | 0.34 USD | |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | — | |
| 08 Mar 2017 | TAX_WITHHOLDING | COMMONWEALTH BIOTECHNOLOGIES INC | 1,470,478 | 0.34 USD | |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | 0.00 USD | deriv |
| 08 Mar 2017 | EXERCISE | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | 0.00 USD | deriv |
| 06 Aug 2014 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | 0.00 USD | deriv |
| 06 Aug 2014 | GRANT_AWARD | COMMONWEALTH BIOTECHNOLOGIES INC | 3,500,000 | 0.00 USD | deriv |
| 24 Aug 2012 | GRANT_AWARD | ACCENTIA BIOPHARMACEUTICALS INC | 109,654 | 0.00 USD | deriv |
| 29 Feb 2012 | GRANT_AWARD | ACCENTIA BIOPHARMACEUTICALS INC | 100,000 | 0.00 USD | deriv |